Through CellChat analysis of scRNA‐seq data from MSS CRC patients, we found that the group with the highest PRMT5 expression exhibited the lowest interaction levels between DCs and T cells (Figure S7G, Supporting Information). Here, PRMT5 is linked to colorectal carcinoma.